186 related articles for article (PubMed ID: 28892067)
1. Association of the serotonin transporter-linked polymorphic region genotype with lower bone mineral density.
Lapid MI; Kung S; Frye MA; Biernacka JM; Geske JR; Drake MT; Jankowski MD; Clarke BL
Transl Psychiatry; 2017 Aug; 7(8):e1213. PubMed ID: 28892067
[TBL] [Abstract][Full Text] [Related]
2. Variants of the serotonin transporter gene, selective serotonin reuptake inhibitors, and bone mineral density in risperidone-treated boys: a reanalysis of data from a cross-sectional study with emphasis on pharmacogenetics.
Calarge CA; Ellingrod VL; Zimmerman B; Bliziotes MM; Schlechte JA
J Clin Psychiatry; 2011 Dec; 72(12):1685-90. PubMed ID: 22244026
[TBL] [Abstract][Full Text] [Related]
3. Use of selective serotonin reuptake inhibitors and bone mass in adolescents: An NHANES study.
Feuer AJ; Demmer RT; Thai A; Vogiatzi MG
Bone; 2015 Sep; 78():28-33. PubMed ID: 25940460
[TBL] [Abstract][Full Text] [Related]
4. The influence of 5-HTTLPR and STin2 polymorphisms in the serotonin transporter gene on treatment effect of selective serotonin reuptake inhibitors in depressive patients.
Smits KM; Smits LJ; Peeters FP; Schouten JS; Janssen RG; Smeets HJ; van Os J; Prins MH
Psychiatr Genet; 2008 Aug; 18(4):184-90. PubMed ID: 18628680
[TBL] [Abstract][Full Text] [Related]
5. Association between a functional serotonin transporter promoter polymorphism and citalopram treatment in adult outpatients with major depression.
Hu XZ; Rush AJ; Charney D; Wilson AF; Sorant AJ; Papanicolaou GJ; Fava M; Trivedi MH; Wisniewski SR; Laje G; Paddock S; McMahon FJ; Manji H; Lipsky RH
Arch Gen Psychiatry; 2007 Jul; 64(7):783-92. PubMed ID: 17606812
[TBL] [Abstract][Full Text] [Related]
6. Association between serotonin transporter-linked polymorphic region and escitalopram antidepressant treatment response in Korean patients with major depressive disorder.
Won ES; Chang HS; Lee HY; Ham BJ; Lee MS
Neuropsychobiology; 2012; 66(4):221-9. PubMed ID: 23095326
[TBL] [Abstract][Full Text] [Related]
7. The impact of 5-HTTLPR on acute serotonin transporter blockade by escitalopram on emotion processing: preliminary findings from a randomised, crossover fMRI study.
Outhred T; Das P; Dobson-Stone C; Felmingham KL; Bryant RA; Nathan PJ; Malhi GS; Kemp AH
Aust N Z J Psychiatry; 2014 Dec; 48(12):1115-25. PubMed ID: 24810870
[TBL] [Abstract][Full Text] [Related]
8. Effect of selective serotonin reuptake inhibitors on bone mineral density: a systematic review and meta-analysis.
Zhou C; Fang L; Chen Y; Zhong J; Wang H; Xie P
Osteoporos Int; 2018 Jun; 29(6):1243-1251. PubMed ID: 29435621
[TBL] [Abstract][Full Text] [Related]
9. Association of low bone mineral density with selective serotonin reuptake inhibitor use by older men.
Haney EM; Chan BK; Diem SJ; Ensrud KE; Cauley JA; Barrett-Connor E; Orwoll E; Bliziotes MM;
Arch Intern Med; 2007 Jun; 167(12):1246-51. PubMed ID: 17592097
[TBL] [Abstract][Full Text] [Related]
10. Role of the serotonin transporter gene locus in the response to SSRI treatment of major depressive disorder in late life.
Seripa D; Pilotto A; Paroni G; Fontana A; D'Onofrio G; Gravina C; Urbano M; Cascavilla L; Paris F; Panza F; Padovani A; Pilotto A
J Psychopharmacol; 2015 May; 29(5):623-33. PubMed ID: 25827644
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms of the serotonin transporter gene and post-stroke depression: a meta-analysis.
Mak KK; Kong WY; Mak A; Sharma VK; Ho RC
J Neurol Neurosurg Psychiatry; 2013 Mar; 84(3):322-8. PubMed ID: 23236014
[TBL] [Abstract][Full Text] [Related]
12. Moderation of antidepressant response by the serotonin transporter gene.
Huezo-Diaz P; Uher R; Smith R; Rietschel M; Henigsberg N; Marusic A; Mors O; Maier W; Hauser J; Souery D; Placentino A; Zobel A; Larsen ER; Czerski PM; Gupta B; Hoda F; Perroud N; Farmer A; Craig I; Aitchison KJ; McGuffin P
Br J Psychiatry; 2009 Jul; 195(1):30-8. PubMed ID: 19567893
[TBL] [Abstract][Full Text] [Related]
13. Fluoxetine response in impulsive-aggressive behavior and serotonin transporter polymorphism in personality disorder.
Silva H; Iturra P; Solari A; Villarroel J; Jerez S; Jiménez M; Galleguillos F; Bustamante ML
Psychiatr Genet; 2010 Feb; 20(1):25-30. PubMed ID: 20010449
[TBL] [Abstract][Full Text] [Related]
14. Impact of 5-HTTLPR on SSRI serotonin transporter blockade during emotion regulation: A preliminary fMRI study.
Outhred T; Das P; Dobson-Stone C; Felmingham KL; Bryant RA; Nathan PJ; Malhi GS; Kemp AH
J Affect Disord; 2016 May; 196():11-9. PubMed ID: 26896742
[TBL] [Abstract][Full Text] [Related]
15. The Relationship between Genotype of Serotonin-transporter-linked Polymorphic Region (5-HTTLPR) and Migraine combined with Depression.
Han L; Yu Z; Mao H
J Coll Physicians Surg Pak; 2021 Aug; 31(8):998-1000. PubMed ID: 34320725
[TBL] [Abstract][Full Text] [Related]
16. Association between serotonin 2A receptor (HTR2A), serotonin transporter (SLC6A4) and brain-derived neurotrophic factor (BDNF) gene polymorphisms and citalopram/sertraline induced sexual dysfunction in MDD patients.
Oz MD; Baskak B; Uckun Z; Artun NY; Ozdemir H; Ozel TK; Ozguven HD; Suzen HS
Pharmacogenomics J; 2020 Jun; 20(3):443-450. PubMed ID: 31792367
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the effect of selective serotonin reuptake inhibitors on bone mineral density: an observational cross-sectional study.
Ak E; Bulut SD; Bulut S; Akdağ HA; Öter GB; Kaya H; Kaya OB; Şengül CB; Kısa C
Osteoporos Int; 2015 Jan; 26(1):273-9. PubMed ID: 25187118
[TBL] [Abstract][Full Text] [Related]
18. Serotonin transporter gene polymorphism associated with short-term treatment response to venlafaxine.
Lee SH; Choi TK; Lee E; Seok JH; Lee SH; Lee HS; Kim SJ
Neuropsychobiology; 2010 Aug; 62(3):198-206. PubMed ID: 20664233
[TBL] [Abstract][Full Text] [Related]
19. Genetic polymorphism in the serotonin transporter gene-linked polymorphic region and response to serotonin reuptake inhibitors in patients with premature ejaculation.
Ozbek E; Otunctemur A; Simsek A; Polat EC; Ozcan L; Köse O; Cekmen M
Clinics (Sao Paulo); 2014 Nov; 69(11):710-3. PubMed ID: 25518026
[TBL] [Abstract][Full Text] [Related]
20. Normal Bone Microstructure and Density But Worse Physical Function in Older Women Treated with Selective Serotonin Reuptake Inhibitors, a Cross-Sectional Population-Based Study.
Larsson B; Mellström D; Johansson L; Nilsson AG; Lorentzon M; Sundh D
Calcif Tissue Int; 2018 Sep; 103(3):278-288. PubMed ID: 29730704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
